Lumiata (acquired by AKASA)

Lumiata, now integrated into the AKASA ecosystem (specifically within the Retrace and Unified Revenue Orchestration platforms), is a specialized AI engine designed for the healthcare industry. Its technical architecture centers around a proprietary Clinical Knowledge Graph and deep learning models trained on billions of healthcare data points, including claims, clinical labs, and pharmacy data. In the 2026 market landscape, Lumiata positions itself as the backbone for healthcare payers and providers to move from reactive to proactive financial management. By utilizing multi-layered neural networks, it transforms fragmented healthcare data into high-fidelity risk scores and cost predictions. The platform's 'Health AI Lab' allows actuarial and clinical teams to build, test, and deploy custom models without the need for extensive data science infrastructure. Its primary value proposition lies in its ability to predict disease progression and associated costs with higher precision than traditional actuarial methods, directly impacting the accuracy of underwriting, stop-loss insurance, and value-based care contracts.